+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Estrogen Replacement Increases β-Adrenoceptor-Mediated Relaxation of Rat Mesenteric Arteries

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The purpose of the present study was to determine whether estrogen replacement in ovariectomized rats could modulate arterial diameter responses to β-adrenoceptor activation. Under relaxed conditions (0.1 mM papaverine) there were no differences in the lumen diameter of isolated, pressurized (50 mm Hg) mesenteric arteries from nontreated (191.7 ± 13.8 µm; n = 19) versus those from estrogen-treated (190.1 ± 11 µm; n = 14) ovariectomized Sprague-Dawley rats. In arteries precontracted with noradrenaline (0.3-1 µM), isoprenaline (0.01–10 µM)-induced relaxation was significantly increased in arteries from ovariectomized estrogen-treated rats (52.4 ± 2% of the maximal relaxation induced by 0.1 mM papaverine, vs. 33.3 ± 6.5%; p < 0.01). The half-maximal concentration value was 0.04 ± 0.05 µ M in estrogen-treated rats and 0.4 ± 0.1 µM in nontreated rats (p < 0.01). This response was inhibited by propranolol (1 µM) in both groups to a comparable extent (61.5%), and was unaffected by endothelial removal. Forskolin (0.01–10 µM) induced similar concentration-dependent vasodilation in arteries of both groups of rats with no differences in sensitivity or maximal response. These results suggest that isoprenaline acts through β-adrenoceptors present on vascular smooth muscle and that estrogen replacement enhances the relaxant responses induced by β-adrenoceptor activation by an endothelium-independent mechanism.

          Related collections

          Author and article information

          J Vasc Res
          Journal of Vascular Research
          S. Karger AG
          24 September 2008
          : 33
          : 2
          : 124-131
          Department of Obstetrics and Gynecology, University of Vermont College of Medicine, Burlington, Vt., USA
          159140 J Vasc Res 1996;33:124–131
          © 1996 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 8
          Research Paper


          Comment on this article